Journey Medical Corporation (DERM) Stock Overview

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026

$7.86
Price
$221.84M
Market Cap
—
P/E Ratio
-$0.22
EPS
$9.55
52-Week High
$4.31
52-Week Low
—
Dividend Yield
USD
Currency

About Journey Medical Corporation

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth…

Source: Yahoo Finance

Sector & Industry

Journey Medical Corporation operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.

Journey Medical Corporation at a Glance

CompanyJourney Medical Corporation
TickerDERM
ExchangeNASDAQ
CurrencyUSD
Price$7.86
Market cap$221.84M
P/E ratio (trailing)—
EPS (trailing)-$0.22
52-week high$9.55
52-week low$4.31
Dividend yield—
Ex-dividend date—
Beta1.10
Return on equity (ROE)-23.77%
Debt-to-equity79.53%
Average volume241,038
Shares outstanding22.22M
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees58
CountryUnited States

Investing Essentials

As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.

AMAZON One Up On Wall Street

Peter Lynch on how everyday investors can spot winners before the professionals do.

Check Price →
AMAZON Healthcare Investing Reads

Evaluating pharma pipelines, devices and healthcare economics.

Check Price →
AMAZON The Intelligent Investor

Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.

Check Price →
Disclaimer: This page is for reference only. Not financial advice. Data is a snapshot and may be out of date. Always verify with a licensed broker.

Frequently Asked Questions

What is Journey Medical Corporation's current P/E ratio?
Journey Medical Corporation (DERM) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
What is Journey Medical Corporation's market capitalisation?
Journey Medical Corporation's market cap is $221.84M based on our latest snapshot. See how it ranks by market cap →
What is DERM's 52-week range?
Over the past 52 weeks, DERM has traded between $4.31 and $9.55. What does the 52-week range mean? →
How volatile is Journey Medical Corporation compared to the market?
Journey Medical Corporation has a beta of 1.10, meaning it has historically moved more than the broader market. What does beta measure? →
Does Journey Medical Corporation pay a dividend?
Journey Medical Corporation does not currently pay a dividend according to our latest data.
What exchange is DERM listed on?
DERM is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
What sector is Journey Medical Corporation in?
Journey Medical Corporation is classified in the Healthcare sector. Compare with Healthcare peers →

Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.

Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.

Recommended Reading & Tools

AMAZON Common Stocks and Uncommon Profits

Philip Fisher on what makes a business worth owning for the long term.

Check Price →
AMAZON A Random Walk Down Wall Street

Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.

Check Price →
AMAZON The Psychology of Money

Morgan Housel's short lessons on behaviour, luck and long-term wealth.

Check Price →

Related Healthcare Stocks